Gerhard P. Baumann
#159,988
Most Influential Person Now
Gerhard P. Baumann's AcademicInfluence.com Rankings
Gerhard P. Baumannphilosophy Degrees
Philosophy
#9201
World Rank
#12723
Historical Rank
Logic
#6190
World Rank
#7679
Historical Rank
Gerhard P. Baumannbiology Degrees
Biology
#12588
World Rank
#16074
Historical Rank
Endocrinology
#190
World Rank
#203
Historical Rank
Molecular Biology
#2060
World Rank
#2092
Historical Rank
Download Badge
Philosophy Biology
Gerhard P. Baumann's Degrees
- PhD Molecular Biology University of California, Berkeley
- Doctorate Medicine Stanford University
Why Is Gerhard P. Baumann Influential?
(Suggest an Edit or Addition)Gerhard P. Baumann's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). (1997) (774)
- Growth hormone heterogeneity: genes, isohormones, variants, and binding proteins. (1991) (438)
- Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. (1996) (433)
- A specific growth hormone-binding protein in human plasma: initial characterization. (1986) (425)
- The effect of circulating growth hormone-binding protein on metabolic clearance, distribution, and degradation of human growth hormone. (1987) (233)
- Familial dwarfism due to a novel mutation of the growth hormone-releasing hormone receptor gene. (1999) (221)
- Basal plasma growth hormone levels in man: new evidence for rhythmicity of growth hormone secretion. (1990) (204)
- The circulating growth hormone (GH)-binding protein complex: a major constituent of plasma GH in man. (1988) (183)
- Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh. (1998) (178)
- Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial. (2004) (168)
- Absence of the plasma growth hormone-binding protein in Laron-type dwarfism. (1987) (156)
- Distribution, blood transport, and degradation of antidiuretic hormone in man. (1976) (156)
- Regulation of plasma growth hormone-binding proteins in health and disease. (1989) (150)
- Simple algebraic and graphic methods for the apportionment of hormone (and receptor) into bound and free fractions in binding equilibria; or how to calculate bound and free hormone? (1989) (134)
- Growth Hormone Binding Protein 2001 (2001) (129)
- Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor -/- mice. (2000) (118)
- Growth hormone isoforms. (2009) (114)
- Secretory patterns of growth hormone during basal periods in man. (1986) (113)
- The Dwarfs of Sindh: severe growth hormone (GH) deficiency caused by a mutation in the GH‐releasing hormone receptor gene (1997) (104)
- Tumor Necrosis Factor-α Converting Enzyme (TACE) Is a Growth Hormone Binding Protein (GHBP) Sheddase: The Metalloprotease TACE/ADAM-17 Is Critical for (PMA-Induced) GH Receptor Proteolysis and GHBP Generation. (2000) (103)
- The molecular nature of circulating growth hormone in normal and acromegalic man: evidence for a principal and minor monomeric forms. (1983) (99)
- Growth hormone doping in sports: a critical review of use and detection strategies. (2012) (99)
- Growth hormone-binding protein activity is inversely related to 24-hour growth hormone release in normal boys. (1991) (97)
- Growth Hormone Heterogeneity in Human Pituitary and Plasma (1999) (96)
- Influence of the high-affinity growth hormone (GH)-binding protein on plasma profiles of free and bound GH and on the apparent half-life of GH. Modeling analysis and clinical applications. (1993) (95)
- Growth Hormone (GH)-induced Dimerization Inhibits Phorbol Ester-stimulated GH Receptor Proteolysis* (2001) (95)
- Laboratory measurement of growth hormone. (2004) (92)
- Low levels of high-affinity growth hormone-binding protein in African pygmies. (1989) (89)
- A second, lower affinity growth hormone-binding protein in human plasma. (1990) (87)
- Plasma "big" and "big-big" growth hormone (GH) in man: an oligomeric series composed of structurally diverse GH monomers. (1984) (86)
- Growth hormone-binding proteins: state of the art. (1994) (83)
- Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues. (1994) (81)
- Molecular forms of circulating growth hormone during spontaneous secretory episodes and in the basal state. (1985) (79)
- Metalloprotease-mediated GH Receptor Proteolysis and GHBP Shedding (2002) (79)
- Serum growth hormone (GH)-binding protein/receptor: an important determinant of GH responsiveness. (1992) (77)
- In vivo kinetics of a covalent growth hormone-binding protein complex. (1989) (76)
- Oxytocin determination by radioimmunoassay in cattle (1979) (73)
- Pituitary hypoplasia in patients with a mutation in the growth hormone-releasing hormone receptor gene. (2000) (73)
- Plasma Growth Hormone (GH)-Binding Proteins: Effect on GH Binding to Receptors and GH Action* (1991) (73)
- Multifactorial control of the elimination kinetics of unbound (free) growth hormone (GH) in the human: regulation by age, adiposity, renal function, and steady state concentrations of GH in plasma. (1996) (71)
- The metabolic clearance, distribution, and degradation of dimeric and monomeric growth hormone (GH): implications for the pattern of circulating GH forms. (1986) (70)
- Growth Hormone Receptor Is a Target for Presenilin-dependent γ-Secretase Cleavage* (2005) (70)
- Blockade of growth hormone receptor shedding by a metalloprotease inhibitor. (1998) (70)
- Growth Hormone-Binding Proteins (1993) (69)
- Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. (1997) (69)
- Slow metabolic clearance rate of the 20,000-dalton variant of human growth hormone: implications for biological activity. (1985) (69)
- Insulin receptors and insulin resistance in human pregnancy: evidence for a postreceptor defect in insulin action. (1982) (68)
- Low Plasma Growth Hormone Binding Protein in IDDM (1992) (68)
- Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency. (1999) (66)
- Insulin resistance and insulin receptors in hepatic cirrhosis. (1982) (64)
- Circulating growth hormone binding proteins (1994) (62)
- Circadian variation of basal plasma growth hormone in man. (1983) (60)
- Growth hormone binding protein. The soluble growth hormone receptor. (2002) (59)
- Growth Hormone Binding Proteins and Various Forms of Growth Hormone: Implications for Measurements (1990) (59)
- Molecular forms of human growth hormone secreted in vivo: nonspecificity of secretory stimuli. (1986) (57)
- The Effect of Lithium on the Osmoregulation of Arginine Vasopressin Secretion (1983) (57)
- Growth hormone-binding protein: II. Studies in pygmies and normal statured subjects. (1990) (54)
- Tumor necrosis factor-alpha converting enzyme (TACE) is a growth hormone binding protein (GHBP) sheddase: the metalloprotease TACE/ADAM-17 is critical for (PMA-induced) GH receptor proteolysis and GHBP generation. (2000) (54)
- Immunochemical similarity of the human plasma growth hormone-binding protein and the rabbit liver growth hormone receptor. (1988) (53)
- The role of body mass in the response to growth hormone therapy. (1992) (50)
- Effects of growth hormone-binding proteins on serum growth hormone measurements. (1991) (49)
- Binding of human growth hormone (GH)-variant (placental GH) to GH-binding proteins in human plasma. (1991) (48)
- Free cortisol index: a rapid and simple estimation of free cortisol in human plasma. (1975) (47)
- Circulating growth hormone forms after stimulation of pituitary secretion with growth hormone-releasing factor in man. (1984) (47)
- Phorbol ester- and growth factor-induced growth hormone (GH) receptor proteolysis and GH-binding protein shedding: relationship to GH receptor down-regulation. (2001) (46)
- Diurnal pattern of plasma growth hormone-binding protein in man. (1990) (45)
- Plasma transport of human growth hormone in vivo. (1990) (44)
- Insulin receptors in acute infection: a study of factors conferring insulin resistance. (1984) (43)
- Endotoxin-induced proteolytic reduction in hepatic growth hormone (GH) receptor: a novel mechanism for GH insensitivity. (2008) (43)
- A kindred with a variant of multiple endocrine neoplasia type 1 demonstrating frequent expression of pituitary tumors but not linked to the multiple endocrine neoplasia type 1 locus at chromosome region 11q13. (1997) (42)
- Growth hormone receptor is a target for presenilin-dependent gamma-secretase cleavage. (2005) (42)
- Plasma arginine vasopressin in the syndrome of inappropriate antidiuretic hormone secretion. (1972) (40)
- Plasma transport of the 20,000-dalton variant of human growth hormone (20K): evidence for a 20K-specific binding site. (1990) (39)
- The Impact of congenital, severe, untreated growth hormone (GH) deficiency on bone size and density in young adults: insights from genetic GH-releasing hormone receptor deficiency. (2003) (39)
- Failure of endogenous prolactin to alter renal salt and water excretion and adrenal function in man. (1976) (38)
- Growth hormone-binding proteins in plasma. (1993) (38)
- Metalloproteinases and the modulation of GH signaling. (2002) (38)
- Growth hormone production by human pituitary glands in organ culture: evidence for predominant secretion of the single-chain 22,000 molecular weight form (isohormone B). (1982) (37)
- The 20,000 Da variant of human growth hormone does not bind to growth hormone receptors in human liver (1990) (37)
- Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance. (2002) (37)
- Short stature and decreased serum growth hormone-binding protein in the Mountain Ok people of Papua New Guinea. (1991) (35)
- Effect of amino acid based dialysis solution on peritoneal permeability and prostanoid generation in patients undergoing continuous ambulatory peritoneal dialysis. (1992) (34)
- The stoichiometry of growth hormone-binding protein complexes in human plasma: comparison with cell surface receptors. (1994) (34)
- Consensus on How to Measure Growth Hormone in Serum (1999) (33)
- Growth hormone-binding proteins (1990) (32)
- Genetic Characterization of Growth Hormone Deficiency and Resistance (2002) (31)
- Decline of plasma growth hormone binding protein in old age. (1996) (29)
- Growth Hormone Binding Protein, Insulin-like Growth Factor-I and Short Stature in Two Pygmy Populations from the Philippines (2002) (29)
- Growth hormone binding protein--errant receptor or active player? (1995) (29)
- Big growth hormone forms in human plasma: immunochemical evidence for their pituitary origin. (1986) (29)
- Metabolism of growth hormone (GH) and different molecular forms of GH in biological fluids. (1991) (29)
- Characteristics of the somatotropic axis in insulin dependent diabetes mellitus. (1995) (27)
- Growth hormone binding to a circulating receptor fragment--the concept of receptor shedding and receptor splicing. (2009) (27)
- Growth hormone-binding protein determination in plasma: a comparison of immunofunctional and growth hormone-binding assays. (1993) (26)
- Appraisal of growth hormone (GH) secretion: evaluation of a composite pharmacokinetic model that discriminates multiple components of GH input. (1999) (26)
- Serum thyroxine and thyroxine-binding proteins in chronic renal failure without nephrosis. (1975) (26)
- A rapid and simple assay for growth hormone-binding protein activity in human plasma. (1988) (24)
- Hepatic insulin and glucagon receptors in pregnancy: their role in the enhanced catabolism during fasting. (1981) (23)
- Metabolic clearance rates of isohormones of human growth hormone in man. (1979) (23)
- The effect of osmotic stimuli on prolactin secretion and renal water excretion in normal man and in chronic hyperprolactinemia. (1977) (22)
- Identification and high yield purification of insulin-like growth factors (nonsuppressible insulin-like activities and somatomedins) from human plasma by use of endogenous binding proteins. (1979) (22)
- Plasma Growth hormone (GH)-binding proteins: effect on GH binding to receptors and GH action (1992) (22)
- Haplotype analysis of the growth hormone releasing hormone receptor locus in three apparently unrelated kindreds from the indian subcontinent with the identical mutation in the GHRH receptor (2003) (22)
- A child with phenotypic Laron dwarfism and normal somatomedin levels. (1989) (21)
- Urinary growth hormone in man: evidence for multiple molecular forms. (1983) (21)
- Serum growth hormone-binding protein is unchanged in adult panhypopituitarism. (1994) (21)
- Mutations in the growth hormonereleasing hormone receptor: a new form of dwarfism in humans (1999) (20)
- Circulating Molecular Variants of Growth Hormone in Childhood (1987) (19)
- Insulin Receptors in Embryo and Extra Embryonic Membranes of Early Somite Rat Conceptus (1986) (18)
- Oxytocin determination by radioimmunoassay in cattle. II. Effect of mating and stimulation of the genital tract in bulls, cows and heifers. (1982) (18)
- A growth hormone/prolactin-binding protein in human milk. (1994) (18)
- Reduced proteolysis of rabbit growth hormone (GH) receptor substituted with mouse GH receptor cleavage site. (2003) (17)
- Voice abnormality in adults with congenital and adult-acquired growth hormone deficiency. (2005) (17)
- Androgen regulation of growth hormone binding protein. (1996) (17)
- Urinary growth hormone excretion rates in normal and acromegalic man: a critical appraisal of its potential clinical utility (1989) (16)
- Growth Hormone Binding Proteins in Plasma – An Update (1990) (16)
- "Trace" contamination of corticotropin and human growth hormone with vasopressin--clinical significance. (1972) (15)
- Heterogeneity of circulating growth hormone. (1994) (15)
- Heterogeneity of Growth Hormone (1988) (14)
- Failure of endogenous plasmin to convert human growth hormone to its "activated" isohormones. (1976) (14)
- Epinephrine-producing pheochromocytoma with hypertensive crisis after corticotropin injection. (1990) (14)
- Plasma estrogens, androgens, and von Willebrand factor in men on chronic hemodialysis. (1988) (14)
- Deletion of the mouse GH-binding protein (mGHBP) mRNA polyadenylation and splicing sites does not abolish production of mGHBP. (1997) (14)
- Growth hormone binding proteins: biochemical characterization and assays. (1991) (13)
- Lack of in vivo transformation of human growth hormone to its "activated" isohormones in peripheral tissues of the rhesus monkey. (1976) (13)
- Growth hormone binding protein and free growth hormone in chronic renal failure (1996) (13)
- Possible therapeutic applications of human growth hormone. (1991) (13)
- Pharmacokinetic studies of highly purified human prolactin in normal human subjects. (1987) (12)
- Mutations in the growth hormone releasing hormone receptor: a new form of dwarfism in humans. (2001) (11)
- Circulating binding proteins for human growth hormone (1989) (11)
- Insights into modulation of (and by) growth hormone signaling. (2000) (10)
- Growth hormone binding protein in human plasma downregulation by prolonged fasting in lean but not obese subjects (1988) (10)
- Isolation of human growth hormone isohormones D and E in milligram amounts (I), using isotachophoresis on polyacrylamide gel. (1981) (9)
- Assay Systems for the Growth Hormone-Binding Protein (1994) (9)
- Estrogens and the hypothalamo-pituitary-adrenal axis in man: evidence for normal feedback regulation by corticosteroids. (1983) (9)
- The autodecomposition of radiolabeled human growth hormone. (1986) (9)
- Corticotropic action of an intra-nasally applied synthetic ACTH derivative. (1976) (9)
- Binding Proteins of Protein Therapeutics (1992) (8)
- Effect of growth hormone administration frequency on 24-hour growth hormone profiles and levels of other growth related parameters in girls with Turner's syndrome. Dutch Working Group on Growth Hormone. (1993) (8)
- Enhanced Efficacy of U-500 Insulin in the Treatment of Insulin Resistance Caused by Target Tissue Insensitivity (1984) (7)
- Editorial: Growth without a Pituitary?-Lessons from the Guinea Pig. (1997) (6)
- Growth hormone-binding protein in human lymph. (1995) (6)
- The Somatotrophic Axis and the Reproductive Process in Health and Disease (1995) (6)
- Relationship Between Serum Growth Hormone Binding Protein Levels and Height in Young Men (2000) (6)
- Molecular Heterogeneity of Circulating Growth Hormone in Acromegaly (1987) (6)
- Correction and withdrawal of conclusion--a child with phenotypic Laron dwarfism and normal somatomedin levels. (1990) (6)
- The orientation of insulin receptors in the red cell membrane (1983) (5)
- Kinetics of cell age-dependent decline of insulin receptors in human red cells. (1984) (5)
- Metalloproteinases and the modulation of growth hormone signalling (2002) (5)
- [Serum transferrin in chronically hemodialysed patients under controlled additional dietetic protein allowance]. (1973) (4)
- Gigantism with hypopituitarism. (1972) (4)
- When Should We Measure Growth Hormone Binding Protein? (2002) (4)
- Growth without a pituitary?--Lessons from the guinea pig. (1997) (3)
- Growth hormone‐binding proteins – an overview (1996) (3)
- GHRH receptor defects. (2002) (3)
- Growth Hormone Replacement Therapy in Adult Onset GH Deficiency : Effects on Body Composition in Men and Women in a Double-Blind , Randomized , Placebo-Controlled Trial (2005) (3)
- Growth Hormone-Releasing Hormone Receptor and Growth Hormone Gene Abnormalities (2016) (2)
- Growth Hormone-Releasing Hormone Receptors and Pituitary Development (2001) (2)
- Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor −/− mice. (2000) (2)
- Somatomedin generation in response to activated and nonactivated isohormones of human growth hormone. (1979) (2)
- Function of GH/IGF-I axis in aging: Multicenter study in 152 healthy elderly subjects with different degrees of physical activity: Italian Association for Research on Brain Aging (AIRIC) Multicenter Study Group (1997) (2)
- Hyponatremia during adrenocorticotropin (ACTH) infusions. (1979) (1)
- Book Review Endocrinology of Aging (Contemporary Endocrinology. No. 20.) Edited by John E. Morley and Lucretia van den Berg. 270 pp., illustrated. Totowa, N.J., Humana Press, 2000. $99.50 0-89603-756-8 (2000) (1)
- Chapter 8. Growth Hormone Binding Proteins (2008) (1)
- Goiter and Renal Failure (1974) (1)
- Effects of prolactin on water and electrolyte excretion during mineralocorticoid escape in man (1975) (1)
- MINI-REVIEW Metalloproteinases and the modulation of GH signaling (2002) (1)
- Prolonged corticotropic action of synthetic human ACTH in man. (1976) (1)
- Growth hormone By Steven Harvey, Colin G. Scanes, and William H. Daughaday. Boca Raton, CRC, $99.95 USA, $119.00 elsewhere (523 pages), ISBN 0-84938697-7 (1995) (1)
- Growth Hormone (GH) (2004) (1)
- Diagnostic Implications of Growth Hormone Binding Proteins (1992) (1)
- MOLECULAR HETEROGENEITY OF CIRCULATING GROWTH HORMONE (1987) (0)
- Erratum: (Journal of Clinical Investigation (February 1993) 91:2 (629- 639)) (1993) (0)
- Letter: Goiter and renal failure. (1974) (0)
- How effective is octreotide-LAR as a primary treatment for growth-hormone-secreting tumors? (2006) (0)
- Human Growth Hormone Binding Proteins: Regulation and Physiological Significance (1995) (0)
- Growing Taller Without Hormones Limb Lengthening – for Whom, When and How? Edited by Z. Laron, S. Mastragostino, and C. Romano (1999) (0)
- Growth Hormone Therapy Comes of (Adult) Age Challenges in Growth Hormone Therapy, edited by John P. Monson (2000) (0)
- American Journal of Medicine, March 1984, pp 529-32 Enhanced efficacy of U-500 insulin in the treatment of insulin resistance caused by target tissue insensitivity (1984) (0)
- 28Th International Symposium on GH and Growth Factors in Endocrinology and Metabolism (2000) (0)
- Book Review Genetics in Endocrinology (Modern Endocrinology Series.) Edited by John D. Baxter, Shlomo Melmed, and Maria I. New. 763 pp., illustrated. Philadelphia, Lippincott Williams & Wilkins, 2002. $169. 0-7817-1496-6 (2002) (0)
- Growth hormone therapy for adult hypopituitarism: the end of exponential growth? (2001) (0)
- Serum transferrin and protein nutrition during chronic intermittent haemodialysis. (1971) (0)
- Role of Growth Hormone Status in the Outcome of Total Knee Replacement (1997) (0)
- Placebo-Controlled Trial Effects on Body Composition in Men and Women in a Double-Blind, Randomized, Growth Hormone (GH) Replacement Therapy in Adult-Onset GH Deficiency: (2004) (0)
- Euthyroid hyperthyroxinemia. (1983) (0)
- PS1292 LINK BETWEEN IRON AND TRYPTOPHAN METABOLISM OBSERVED IN INDIVIDUALS WITH IRON DEFICIENCY AND ANEMIA (2019) (0)
- BRIEF REPORT Voice Abnormality in Adults with Congenital and Adult- Acquired Growth Hormone Deficiency (2005) (0)
- A Syndrome of Phenotypic Laron‐Type Dwarfism with Normal Levels of Insulin‐like Growth Factor I (1989) (0)
- [Forced diuresis and urea excretion in advanced kidney failure]. (1973) (0)
- Growth hormone therapy for adults: an adolescent field at age 16 Jens Otto Lunde Jørgensen (2006) (0)
- [Nitrogen balance studies in various amino acid infusions]. (1973) (0)
- Hormone action: insights from disruptions Hormone Resistance and Hypersensitivity States edited by George P. Chrousos, Jerrold M. Olefsky and Ellis Samols. Lippincott Williams and Wilkins, 2002. US$149 (xiv+542 pages) ISBN 0 7817 1497 4 (2003) (0)
- Influence of mating behaviour and stimulation of the genital organs on oxytocin release in cattle. (1980) (0)
- Erratum to “Disproportional skeletal growth and markedly decreased bone mineral content in growth hormone receptor −/− mice” [Biochem. Biophys. Res. Commun. 267 (2000) 603–608] (2006) (0)
- U-500 insulin for insulin resistance. (1985) (0)
This paper list is powered by the following services:
